Clinical trial
Randomized Controlled Clinical Trial (RCT) of the Nectero EAST System for Small to Mid-Sized Abdominal Aortic Aneurysms (AAA) StaBiLization: Evaluation of Efficacy.
NCT06001918 is registered in ClinicalTrials.gov with Nectero Medical, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Controlled Clinical Trial (RCT) of the Nectero EAST System for Small to Mid-Sized Abdominal Aortic Aneurysms (AAA) StaBiLization: Evaluation of Efficacy.
- Lead sponsor
- Nectero Medical, Inc.
- Phase
- Phase 2/3
- Overall status
- Recruiting
- Start date
- October 25, 2023
- Completion date
- December 31, 2032
- Enrollment
- 400 (estimated)
- Sites
- 42
Conditions
As the registry lists them; a condition with its own page is linked.
abdominal aortic aneurysm